Edition:
United States

BIOLASE Inc (BIOL.OQ)

BIOL.OQ on NASDAQ Stock Exchange Capital Market

1.17USD
26 May 2017
Change (% chg)

$-0.01 (-0.85%)
Prev Close
$1.18
Open
$1.19
Day's High
$1.19
Day's Low
$1.16
Volume
5,203
Avg. Vol
19,162
52-wk High
$1.97
52-wk Low
$0.86

BIOL.OQ

Chart for BIOL.OQ

About

BIOLASE, Inc. (BIOLASE) is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The Company markets, sells, and distributes dental imaging equipment, including cone beam digital x-rays and computer-aided design (CAD)/computer-aided manufacturing (CAM) intra-oral... (more)

Overall

Beta: 2.04
Market Cap(Mil.): $79.46
Shares Outstanding(Mil.): 67.91
Dividend: --
Yield (%): --

Financials

  BIOL.OQ Industry Sector
P/E (TTM): -- 44.95 17.41
EPS (TTM): -0.28 -- --
ROI: -69.46 8.89 -5.42
ROE: -87.08 13.82 -4.68

BRIEF-Biolase announces management change

* Accepted resignation of recently named chief financial officer Mark J. Nelson

May 05 2017

BRIEF-BIOLASE Q1 loss per share $0.06

* Q1 revenue fell 1 percent to $10.9 million Source text for Eikon: Further company coverage:

May 03 2017

BRIEF-Biolase to raise $10.5 mln from institutional and individual investors in a private placement

* Biolase to raise $10.5 million from institutional and individual investors in a private placement

Apr 13 2017

BRIEF-Biolase announces the FDA clearance and worldwide launch of its new Epic Pro diode laser system

* Biolase announces the FDA clearance and worldwide launch of its new Epic Pro(tm) diode laser system

Jan 23 2017

BRIEF-BIOLASE announces management change

* BIOLASE Inc - senior vice president and chief financial officer David C. Dreyer has decided to resign effective January 13, 2017

Jan 09 2017

More From Around the Web

Earnings vs. Estimates